key: cord-1041288-itcld9tm
authors: Aquino, Adriano; Paschoalin, Vania Margaret Flosi; Tessaro, Leticia Louize Gonçalves; Raymundo-Pereira, Paulo A.; Conte-Junior, Carlos Adam
title: Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: A systematic review
date: 2022-01-25
journal: J Pharm Biomed Anal
DOI: 10.1016/j.jpba.2022.114608
sha: b5d1acf18781274a469490b1a28c310d03d1ff3d
doc_id: 1041288
cord_uid: itcld9tm

Coronavidae viruses, such as SARS-CoV, SARS-CoV-2, and MERS-CoV, cause severe lower respiratory tract infection, acute respiratory distress syndrome and extrapulmonary manifestations, such as diarrhea and fever, eventually leading to death. Fast, accurate, reproductible, and cost-effective SARS-CoV-2 identification can be achieved employing nano-biosensors, reinforcing conventional methodologies to avoid the spread of COVID-19 within and across communities. Nano-biosensors built using gold, silver, graphene, In(2)O(3) nanowire and iron oxide nanoparticles, Quantum Dots and carbon nanofibers have been successfully employed to detect specific virus antigens – nucleic acid sequences and/or proteins –or host antibodies produced in response to viral infection. Biorecognition counterpart molecules have been immobilized on the surface of these nanomaterials, leading to selective virus detection by optical or electrochemical transducer systems. This systematic review assessed studies on described and tested immunonsensors and genosensors designed from distinct nanomaterials available at the Pubmed, Scopus, and Science Direct databases. Twenty-three nano biosensors were found suitable for unequivocal coronavirus detection in clinical samples. Nano-biosensors coupled to RT-LAMP/RT-PCR assays can optimize RNA extraction, reduce analysis times and/or eliminate sophisticated instrumentation. Although promising for the diagnosis of Coronavidae family members, further trials in large populations must be adequately and rigorously conducted to address nano-biosensor applicability in the clinical practice for early coronavirus infection detection.

SARS-CoV, the virus that causes the severe acute respiratory coronavirus syndrome SARS-CoV-2, and MERS-CoV, the causative agent of Middle East respiratory syndrome infection, have brought the world to attention in the last decades [1] [2] [3] [4] .

The genome of these viruses presents high homology, with SARS-CoV-2 displaying a 79.5% homology to the SARS-CoV genome and 50% homology to the MERS-CoV genome. Besides the pathogenicity common to the members of this family, SARS-CoV-2, the etiologic agent of COVID-19 may cause severe infection and overall inflammation status, culminating with multiple organ failure, and is a highly transmissible virus. The SARS-CoV-2 genome comprises a 30 kb single positivestranded RNA encoding 10 genes [5] [6] [7] [8], a spike (S) glycoprotein with affinity to the host cell receptor, known as angiotensin-converting enzyme 2 (ACE 2), the small envelope (E) and matrix (M) protein, both essential for virus assembly, the nucleocapsid (N) protein, and several other accessory proteins. SARS-CoV-2 can enter cells by recognizing the angiotensin-converting enzyme 2 (ACE2) through a viral receptorbinding domain located in the S protein [9] [10] . The M protein is responsible for transmembrane nutrient transport and virus envelope formation, and N and E proteins, as well as other several accessory proteins, obstruct the host immune response and present different functions [11] .

The S and N proteins are among the most valuable antigen biomarkers for the diagnosis of COVID-19 [12] [13] [14] . The S protein displays the lowest sequence homology rate among the SARS-CoV and MERS virus genomes, indicating that it may be used as an antigen target in SARS-CoV-2 identification [6] [15] [16] [17] .

Infected and asymptomatic individuals can quickly spread the disease, increasing the number of disease focal points and deaths [11] [18] . In November 2002, SARS-CoV emerged and culminated in over 8,000 cases, followed by MERS-CoV in January 2018, resulting in 2,143 confirmed cases, while SARS-CoV-2 has led to the current COVID-19 pandemic that began in December 2019 [19] [20] [21] . It is estimated that the number of confirmed COVID-19 cases and deaths have reached 167,492,769 and 3,482,907, respectively, on 26 th May, 2021, according to the World Health Organization (WHO) [22] . SARS-CoV spread quickly and globally, resulting in large-scale outbreaks in different countries on all continents [23] . Early diagnosis of SARS-CoV-2-infected individuals is required to contain the COVID-19 pandemic and has been recognized as a successful strategy in several countries [17] . In the future, quick and easy SARS-CoV-2 diagnoses will represent the most powerful epidemiological tool and innovative methods must be developed to test and ensure the health status of large populations.

SARS-CoV-2 detection or quantification based on RNA sequences coding for viral proteins has been applied in the detection of the virus in clinical, biological, and environmental samples employing reverse transcriptase PCR (RT-PCR) [24] and quantitative RT-PCR (qRT-PCR) [25] [26] [27] . Immunological assays, such as lateral flow immunoassays (LFIA), enzyme-linked immunosorbent assays (ELISA), and chemiluminescence enzyme immunoassays (CLIA).have also been used to detect the presence of IgM and/or IgG immunoglobulins against SARS-CoV-2 in blood samples [28] [10] .

A breakthrough in PCR detection systems comprises loop-mediated isothermal amplification (LAMP), allowing for coronavirus DNA detection in less than 60 minutes [29] . However, to prevent the transmission of infectious diseases in large populations, J o u r n a l P r e -p r o o f comprehensive but unequivocal and low-cost virus detection testing methods are required. In this sense, biosensors comprise portable, less expensive, simpler, and faster systems capable of detecting viruses in biological samples.

The possibilities concerning nano-analytical devices consisting of biological recognition apparatuses for the identification of coronavirus target molecules employing physical-chemical transducers to convert viral recognition into analytical signals are displayed in Figure 1 . Different nanomaterials can be used to manufacture nanodevices displaying unique and novel features, functionalities, and applicabilities [30] . The diagnosis and unequivocal biorecognition of COVID-19 employing virus biomarkers and biochemical indicators such as antigens, RNA sequences, proteins, or the entire virus itself can be performed by binding target molecules to these devices, and nano-biosensors carrying these biomarkers provide accurate, fast, and precise viral identification [31] . The combination of these elements makes it possible to design highly sensitive and selective nano-biosensor devices to detect SARS-CoV-2 in response to demands for early detection of infected individuals within large populations.

The present review provides a systematic analysis of innovative nano-biosensing systems applied or adapted to coronavirus detection. Different sensing strategies based on DNA receptors, aptamers, or antibodies immobilized onto nanoparticles coupled to J o u r n a l P r e -p r o o f transducers aiming at the detection of coronaviruses in clinical samples are presented and discussed. Nano-biosensors designed to detect SARS-CoV, SARS-CoV-2, and MERS-CoV viruses are discussed in terms of their effectiveness, simplicity, low costs, integration, and portability, allowing for their operation near patients by untrained people, dispensing sophisticated or expensive equipment.

The search for studies concerning nano-biosensors was performed through the evaluation of keywords, titles, and abstracts. Studies that did not assess nano-biosensor applicability in the detection of coronaviruses and those employing biosensors and nanomaterials or aimed at the detection of other viruses that do not belong to the Coronavidae family were excluded. Only articles published in English from 2000 to 2021 were considered. The systematic review search and preparation followed the preferred reporting items for systematic review and meta-analyses statement (PRISMA) [32] . All available data obtained from the three scientific databases addressing biosensors employing nanoparticles for coronavirus detection were included.

Focus questions were prepared based on the problem, intervention, comparison, and outcome (PICO) method, established as follows: Which nanoparticle-based biosensors are used for coronavirus detection? What strategies have been applied the most concerning DNA-based biosensors or immuno-based biosensors for coronavirus detection? Which nano-biosensor exhibits the lowest limit of detection (LOD)? Which coupled transducers were used to build these biosensors?

J o u r n a l P r e -p r o o f Scientific data were collected from the PubMed, Scopus, and Science Direct databases. followed four main steps: (i) guiding question formulation; (ii) database searching; (iii); eligibility; and (iv) inclusion.

The selection and exclusion criteria listed in Table 1 are based on studies using nanomaterials and biosensors for the detection of coronaviruses and assessments regarding their LOD. This review considered only original research articles. The studies were selected based on the reading of titles and abstracts independently identified and, when these were not enough, the entire study was carefully read. The flowchart of the study selection carried out herein is displayed in Figure 2 . The search was performed using the following components for every database: 

A total of 172 studies were found at the Science Direct database, 923 at the Scopus 

Concerning COVID-19, the World Health Organization (WHO) recommends the collection of samples from the upper respiratory tract through nasopharyngeal swabs or from the lower respiratory tract employing endotracheal sputum aspiration [33] .

Coronavirus mRNA can be detected by the amplification of specific sequences through the transcriptase reverse-polymerase chain reaction (RT-PCR) method, considered the gold standard for molecular diagnosis [34] . Although several improvements have been made to this methodology to reduce the analysis time, it can still take from 40 min to 3 J o u r n a l P r e -p r o o f h, and requires thorough sample handling, trained technicians, certified laboratories and mid-cost equipment. mRNA extraction is a crucial pre-analytical step for RT-PCR application, as it may generate false-negative results if not conducted appropriately.

These limitations make it difficult to develop this methodology into a field application or for the screening of a significant number of samples as required during the current COVID-19 pandemic, which necessitates a quick but unequivocal diagnosis [35] .

Serological tests based on enzyme-linked immunosorbent assay (ELISA) for IgM antibody detection can also be used for coronavirus diagnosis, but the period between infection and seroconversion analysis to carry out these tests make them unfeasible for early and large-scale diagnoses [14] [28] [36] [34] . Based on these considerations, the development of highly sensitive screening tests able to detect lower IgM antibody levels or lower viral loads may be useful in diagnosing the early stages of viral infection.

Nanomaterials (NMs) less than 100 nm in size provide a greater surface volume, enhancing their intrinsic physicochemical properties and increasing their susceptibility to external influences when compared to the bulk material. Depending on NM composition, morphology, and size, these compounds may be used in very specialized applications, such as in special nanostructures made from iron or transition metals whose magnetic properties can be used for biosensing [ J o u r n a l P r e -p r o o f

The results of this systematic review addressing nano-biosensors, biorecognition elements, nanomaterials, sensitivity, and detected Coronaviridae members family are presented in Table 2 .

Nucleotide-based biosensors or genosensors are designed by immobilizing a specific single-strand nucleotide employing a ligand, such as thiol or biotin, to the biosensor matrix. When samples contain viral RNA, hybridization occurs between the target sequence in the virus genome and the ssDNA probe coupled to the biosensor matrix,

where the double-strand ssDNA probe forms a 3D double-strand nucleic molecule and becomes stable, allowing for signal amplification by a transducer [31] . Since the hybridization is very stringent, DNA-based sensors can be applied to detect SARS- 

When employed in biosensors, NMs display the advantage of a high signal-tonoise ratio aimed at highly sensitive and selective diagnoses, as noted for the nanodevices included in Table 2 

The use of viral DNA bound to nano-biosensors for the diagnosis of COVID-19 has also been validated in the studies included in this systematic review, and genosensors have also been proven efficient for screening and detecting coronavirus family members in clinical samples. Furthermore, genosensors can be designed or adapted to detect any SARS-CoV-2 virus variant, as they can target specific regions within the viral genome, resulting in specific nano biosensors to discriminate base substitutions in RNA sequences, for rapid tracking of recent mutations and revealing which specific variant is in circulation in a given area or population.

As mentioned previously, nano-biosensors display high specificity due to their nanobased structure and linked virus capsid or core molecules or antibodies, thus comprising nanodevices employed for the specific recognition of a particular virus. However, the target recognition must be transduced into a signal generated when the viral molecule interacts with the biorecognition element. The recognition signal can be detected by several transducers, giving rise to the broad applicability of these nanodevices.

Electrical signal detectors can be generated from an electrochemical transducer, i.e., amperometric, potentiometric, conductometric, or impedimetric biosensors, while optical signals can also be detected, as in SPR, chemiluminescence, fluorescence or optical fiber or SPR transducers [31] .

Optical transducers are probably the most applied for clinical analyses, due to their selectivity and sensitivity, allowing for broad use in COVID-19 diagnosis [70] [71] .

Colorimetric detectors suitable for sample color change assessments by the naked eye and compound quantification through optical detectors are commonly applied in nanodevices, as well as in conventional methodologies [72] . Early, low-cost, and rapid diagnoses make it possible to identify infected but asymptomatic individuals, minimizing the spread of the disease. In this sense, a plasma optic fiber absorption (P-FAB) biosensor was developed for the specific detection of proteins from the SARS-CoV-2 virus in saliva samples with minimal sample manipulation [56] .

Developed biosensors display several advantages in comparison to the gold standard methods of PCR and ELISA in the diagnosis of COVID-19. Genes targeted by RT-PCR are the same used in biosensing methods, including the genomic sequences encoding protein N, envelope protein (E), spike protein (S), RdRp, and ORF 1ab genes [73] . Due to COVID-19 pandemic, the detection of nucleic acid sequences from SARS-CoV-2 by

RT-PCR has become the leading indicator for the diagnosis of this disease. However, RT-PCR is not fast (3h -6 h) and requires several steps, making this method expensive and unfeasible in high demand in developing countries, which can contribute to increased non-testing or even false-negative results [47] [21] [14] .

Currently, early diagnosis is indispensable to prevent COVID-19 transmission, and serological tests like ELISA are not reliable for early diagnosis, because of the time for seroconversion, making necessary to have sensitive methods but designed for the direct detection of the viral antigen. Among coronavirus antigens, the structural proteins N, S, M, and E,, but particularly, the S and N proteins, are the most commonly used as biomarkers to distinguish coronavirus family members currently employed in biosensing devices [14] . 

The authors declare no conflicts of interest. 

Effective inhibition of MERS-CoV infection by resveratrol

Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies

Repurposing of sitagliptin-melittin optimized nanoformula against sars-cov-2: Antiviral screening and molecular docking studies

Interaction of remdesivir with clinically relevant hepatic drug uptake transporters

Variant analysis of SARS-CoV-2 genomes

Does SARS-CoV-2 has a longer incubation period than SARS and MERS?

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

5G-enabled ultra-sensitive fluorescence sensor for proactive prognosis of COVID-19

COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics

Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2

Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins

Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan

Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor

Development of a low-cost cotton-tipped electrochemical immunosensor for the detection of SARS-CoV-2

An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes

Development of a portable, ultra-rapid and ultra-sensitive cell-based biosensor for the direct detection of the SARS-CoV-2 S1 spike protein antigen

Rapid SARS-CoV-2 detection using electrochemical immunosensor

Drug repurposing for COVID-19 treatment by integrating network pharmacology and transcriptomics

RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein

A rapid and specific assay for the detection of MERS-CoV

Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles

WHO. Novel coronavirus -COVID19

Biomedical Text Link Prediction for Drug Discovery : A Case Study with COVID-19

Evaluation of a real-time reverse transcription-PCR (RT-PCR) assay for detection of middle east respiratory syndrome coronavirus (MERS-COV) in clinical samples from an outbreak in South Korea in 2015

Cross-sectional quantitative RT-PCR study of feline coronavirus viremia and replication in peripheral blood of healthy shelter cats in Southern California

Optimized qRT-PCR Approach for the Detection of Intra-and Extra-Cellular SARS-CoV-2 RNAs

Development of a paper-based analytical device for colorimetric detection of select foodborne pathogens

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

Ten-minute direct detection of Zika virus in serum samples by RT-LAMP

Nano-oddities": unusual nucleic acid assemblies for DNA-based nanostructures and nanodevices

Label-free graphene oxide-based SPR genosensor for the quantification of microRNA21

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and panther fusion system

Sensitive detection and of SARS-CoV-2 by multiplex droplet digital RT-PCR

Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis

ELISA Assay for detection of IgA and IgG antibodies

Aptamers for respiratory syncytial virus detection

Can the surface modification and/or morphology affect the ecotoxicityof zinc oxide nanomaterials? Chemosphere

Hybrid Soft Nanomaterials Composed of DNA Microspheres and Supramolecular Nanostructures of Semi-artificial Glycopeptides

Ultra-sensitive viral glycoprotein detection NanoSystem toward accurate tracing SARS-CoV-2 in biological/non-biological media

Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay

Homogeneous circle-tocircle amplification for real-time optomagnetic detection of SARS-CoV-2 RdRp coding sequence

eCovSens-Ultrasensitive Novel In-House Built Printed Circuit Board Based Electrochemical Device for Rapid Detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV

Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19

Development of RNA-based assay for rapid detection of SARS-CoV-2 in clinical samples

Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection

Quantitative and sensitive detection of SARS coronavirus nucleocapsid protein using quantum dots-conjugated RNA aptamer on chip

Novel system for detecting SARS coronavirus nucleocapsid protein using an ssDNA aptamer

Electrochemical immunosensor for anti-tissue transglutaminase antibodies based on the in situ detection of quantum dots

Electrochemical immunosensors -A powerful tool for analytical applications

A self-assembled fusion protein-based surface plasmon resonance biosensor for rapid diagnosis of severe acute respiratory syndrome

Label-free electrochemical immunosensor based on gold and iron-oxide nanoparticle co-modified rGO-TEPA hybrid for sensitive detection of carcinoembryonic antigen

Colorimetric test for fast detection of SARS-COV-2 in nasal and throat swabs

Label-free, electrical detection of the SARS virus n-protein with nanowire biosensors utilizing J o u r n a l P r e -p r o o f antibody mimics as capture probes

A Fiber-Optic Biosensor Device for Rapid Detection of COVID-19

A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2

Gold Nanorod Assisted Enhanced Plasmonic Detection Scheme of COVID-19 SARS-CoV-2 Spike Protein

Development of Label-Free Colorimetric Assay for MERS-CoV Using Gold Nanoparticles

Ultrasensitive, and Quantitative Detection of SARS-CoV-2 Using Antisense Oligonucleotides Directed Electrochemical Biosensor Chip

Multiplex paper-based colorimetric DNA sensor using pyrrolidinyl peptide nucleic acid-induced AgNPs aggregation for detecting MERS-CoV, MTB, and HPV Oligonucleotides

Genosensor for SARS virus detection based on gold nanostructured screen-printed carbon electrodes

Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19

A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2. bioRxiv 2020, 518055

Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in

The FDAapproved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Clinical features of patients infected with 2019 novel coronavirus in

Performance and clinical validation of the RealStar® MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA

Extensive Viable Middle East Respiratory Syndrome (MERS) Coronavirus Contamination in Air and Surrounding Environment in MERS Isolation Wards

An Optical Urate Biosensor Based on Urate Oxidaseand Long-Lifetime Metalloporphyrins

Paper-based miniaturized immunosensor for naked eye ALP detection based on digital image colorimetry integrated with smartphone

Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay

FITC (fluorescein)-/digoxin-and biotin-labeled primers; pcMNPs -poly (amino ester) with carboxyl groups (PC)-coated magnetic nanoparticles; ASOS -thiol-modified antisense oligonucleotides specific for N-gene